Showing results (251-260 of 299) with videos related to
Sort By:
Pageof 30
The British Journal of Dermatology|January 17, 2007
A classification of psoriasis vulgaris according to phenotypeC E M Griffiths, E Christophers, J N W N Barker, et al.NMR in Biomedicine|May 23, 2007
NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolismUdo F H Engelke, Jörn Oliver Sass, Rudy N Van Coster, et al.Journal of Inherited Metabolic Disease|March 9, 2019
Functional disruption of pyrimidine nucleoside transporter CNT1 results in a novel inborn error of metabolism with high excretion of uridine and cytidineR A Wevers, M Christensen, U F H Engelke, et al.American Journal of Human Genetics|May 10, 2000
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-CR P Nair, P Stuart, T Henseler, et al.Journal of the American Academy of Dermatology|April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trialP Mayser, U Mrowietz, P Arenberger, et al.Clinical Chemistry|November 25, 2003
N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolismUdo F H Engelke, Maria L F Liebrand-van Sambeek, Jan G N de Jong, et al.Nature Genetics|June 1, 1997
Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophyA D Irvine, L D Corden, O Swensson, et al.Metabolomics : Official Journal of the Metabolomic Society|May 3, 2020
A comparison of high-throughput plasma NMR protocols for comparative untargeted metabolomicsNikolaos G Bliziotis, Udo F H Engelke, Ruud L E G Aspers, et al.Metabolomics : Official Journal of the Metabolomic Society|May 22, 2020
Correction to: A comparison of high‑throughput plasma NMR protocols for comparative untargeted metabolomicsNikolaos G Bliziotis, Udo F H Engelke, Ruud L E G Aspers, et al.Plos One|August 13, 2013
Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patientsHenricus A M Mutsaers, Udo F H Engelke, Martijn J G Wilmer, et al.Pageof 30